| Net loss | -244K |
| Depreciation and amortization | 898K |
| Amortization of forgivable loans to brokers | |
| Amortization of deferred financing costs | |
| Amortization of note discount | |
| Fair value of options | |
| Fair value of warrant issuance | |
| Provision bad debt | 121K |
| Net realized and unrealized gain on securities | |
| Non-controlling interest | |
| Increase in fair value of derivative liabilities | |
| Deposits with clearing organizations | -25K |
| Receivables from broker-dealers, clearing organizations and others | -532K |
| Other receivables | -264K |
| Advances to registered representatives | 493K |
| Securities owned: marketable, at market value | -635K |
| Securities owned: non-marketable, at fair value | |
| Other assets | 206K |
| Accounts payable, accrued expenses and other liabilities | -727K |
| Payable to broker dealers and clearing organizations | |
| Securities sold, but not yet purchased, at market | |
| Net cash provided by (used in) operating activities | -1.88M |
| Redemption of note receivable | |
| Investment in unconsolidated joint venture | |
| Purchase of fixed assets | -470K |
| Net cash used in investing activities | -470K |
| Net proceeds from subordinated borrowings | |
| Principal repayment of notes payable | |
| Proceeds from issuance of common stock | |
| Proceeds from issuance of preferred stock | |
| Payment of financing costs | |
| Net cash provided by financing activities | -86K |
| NET INCREASE (DECREASE) IN CASH | -2.44M |
| Beginning of the fiscal year | 24.64M |
| End of the period | 22.21M |
| Interest | 16K |
| Income taxes | 76K |
| Preferred stock dividends | |
| Reclassification of liability contracts to equity | |
| Embedded conversion features upon issuance | |